Top News

Jan 18, 2017
A new document discusses the exclusivity period for authorized generics, but does not tackle the issue of pay-for-delay agreements.
Jan 17, 2017
FDA released a long-awaited draft guidance to help sponsors seeking to demonstrate interchangeability for biosimilar products.
Jan 11, 2017
Industry experts identify the future focus of the biopharma industry in a new survey.
Jan 05, 2017
By BioPharm International Editors
J&J’s Innovation Global announced the company has entered into 15 new collaborations.
Jan 05, 2017
BioPharm International
The number of novel drugs approved in 2016 by FDA’s CDER department was half the number approved the previous year; many of the complete response letters issued in 2016 were a result of preapproval inspection.
Dec 15, 2016
By BioPharm International Editors
Lonza adds CDMO, capsule, and consumer healthcare and nutrition capabilities with $5.5-billion acquisition of Capsugel.
Dec 01, 2016
The House-approved 21st Century Cures legislation supports initiatives for medical research, drug development, and faster approvals, but comes up short on actual appropriations.
Nov 09, 2016
What’s ahead for the healthcare and pharmaceutical industries?
Oct 27, 2016
By BioPharm International Editors
Teva and IBM expanded their partnership to focus on drug development and chronic disease management.
Oct 24, 2016
FDA’s new Office of Tissues and Advanced Therapies will oversee a growing range of cellular and genetic products.
lorem ipsum